BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr | ₹17 Cr |
What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹54 Cr |
Mar2023 | ₹46 Cr |
Mar2022 | ₹22 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹17 Cr |
How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹54 Cr | 16.37 | |
Mar2023 | ₹46 Cr | 111.13 | |
Mar2022 | ₹22 Cr | -9.45 | |
Mar2021 | ₹24 Cr | 42.17 | |
Mar2020 | ₹17 Cr | - |
Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹213.4 Cr | 7.8% | 18.5% | 15.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 7.8% |
18.5% |
15.7% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses